Among the various components contained in bee venom, bee venom-derived PLA2 (bvPLA2; GenBank accession no. AFI40558.1), which belongs to group III secretory PLA2 with a molecular weight of 14 to 18 kDa, is known to have various pharmacological effects, including an anti-neurodegenerative effect, an anti-inflammatory effect, an anti-nociceptive effect, an anti-cancer effect, and an anti-bacterial effect [7]. The gene discussed is PLA2G2A; the disease is cancer.